• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

壳聚糖在眼部药物递送中的潜力。

The potential of chitosan in ocular drug delivery.

作者信息

Alonso María José, Sánchez Alejandro

机构信息

Department of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of Santiago de Compostela, 15782 Santiago de Compostela, Spain.

出版信息

J Pharm Pharmacol. 2003 Nov;55(11):1451-63. doi: 10.1211/0022357022476.

DOI:10.1211/0022357022476
PMID:14713355
Abstract

This paper presents an overview of the potential of chitosan-based systems for improving the retention and biodistribution of drugs applied topically onto the eye. Besides its low toxicity and good ocular tolerance, chitosan exhibits favourable biological behaviour, such as bioadhesion- and permeability-enhancing properties, and also interesting physico-chemical characteristics, which make it a unique material for the design of ocular drug delivery vehicles. The review summarizes the techniques for the production of chitosan gels, chitosan-coated colloidal systems and chitosan nanoparticles, and describes their mechanism of action upon contact with the ocular mucosa. The results reported until now have provided evidence of the potential of chitosan gels for enhancing and prolonging the retention of drugs on the eye surface. On the other hand, chitosan-based colloidal systems were found to work as transmucosal drug carriers, either facilitating the transport of drugs to the inner eye (chitosan-coated colloidal systems containing indometacin) or their accumulation into the corneal/conjunctival epithelia (chitosan nanoparticles containing ciclosporin). Finally, the tolerance, toxicity and biodegradation of the carriers under evaluation were reviewed.

摘要

本文概述了基于壳聚糖的体系在改善眼部局部用药的药物滞留和生物分布方面的潜力。除了低毒性和良好的眼部耐受性外,壳聚糖还表现出良好的生物学行为,如生物黏附性和通透性增强特性,以及有趣的物理化学特性,这使其成为设计眼部药物递送载体的独特材料。该综述总结了壳聚糖凝胶、壳聚糖包衣胶体系统和壳聚糖纳米颗粒的制备技术,并描述了它们与眼黏膜接触时的作用机制。目前报道的结果证明了壳聚糖凝胶在增强和延长药物在眼表面滞留方面的潜力。另一方面,发现基于壳聚糖的胶体系统可作为透黏膜药物载体,要么促进药物向眼内转运(含吲哚美辛的壳聚糖包衣胶体系统),要么使其在角膜/结膜上皮中蓄积(含环孢素的壳聚糖纳米颗粒)。最后,对所评估载体的耐受性、毒性和生物降解进行了综述。

相似文献

1
The potential of chitosan in ocular drug delivery.壳聚糖在眼部药物递送中的潜力。
J Pharm Pharmacol. 2003 Nov;55(11):1451-63. doi: 10.1211/0022357022476.
2
Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP).脂质体-壳聚糖纳米颗粒复合物(LCS-NP)介导的眼部药物递送
Biomaterials. 2007 Mar;28(8):1553-64. doi: 10.1016/j.biomaterials.2006.11.028. Epub 2006 Dec 13.
3
Chitosan nanoparticles for drug delivery to the eye.用于眼部给药的壳聚糖纳米粒
Expert Opin Drug Deliv. 2009 Mar;6(3):239-53. doi: 10.1517/17425240902762818.
4
Transmucosal macromolecular drug delivery.经黏膜大分子药物递送
J Control Release. 2005 Jan 3;101(1-3):151-62. doi: 10.1016/j.jconrel.2004.07.030.
5
Bioadhesive hyaluronan-chitosan nanoparticles can transport genes across the ocular mucosa and transfect ocular tissue.生物黏附性透明质酸-壳聚糖纳米颗粒可携带基因穿过眼黏膜并转染眼组织。
Gene Ther. 2008 May;15(9):668-76. doi: 10.1038/gt.2008.16. Epub 2008 Feb 28.
6
Liposome coated with low molecular weight chitosan and its potential use in ocular drug delivery.低分子量壳聚糖包被的脂质体及其在眼部药物递送中的潜在应用。
Int J Pharm. 2009 Sep 8;379(1):131-8. doi: 10.1016/j.ijpharm.2009.06.020. Epub 2009 Jun 25.
7
Review paper: chitosan derivatives as promising materials for controlled drug delivery.综述论文:壳聚糖衍生物作为可控药物递送的有前景材料
J Biomater Appl. 2008 Jul;23(1):5-36. doi: 10.1177/0885328208091562.
8
Chitosan nanoparticles as a potential drug delivery system for the ocular surface: toxicity, uptake mechanism and in vivo tolerance.壳聚糖纳米颗粒作为一种潜在的眼表药物递送系统:毒性、摄取机制及体内耐受性
Invest Ophthalmol Vis Sci. 2006 Apr;47(4):1416-25. doi: 10.1167/iovs.05-0495.
9
Chitosan: a unique polysaccharide for drug delivery.壳聚糖:一种用于药物递送的独特多糖。
Drug Dev Ind Pharm. 1998 Nov;24(11):979-93. doi: 10.3109/03639049809089942.
10
Polyoxyethylated nonionic surfactants and their applications in topical ocular drug delivery.聚氧乙烯化非离子表面活性剂及其在局部眼部给药中的应用。
Adv Drug Deliv Rev. 2008 Dec 14;60(15):1663-73. doi: 10.1016/j.addr.2008.09.002. Epub 2008 Sep 20.

引用本文的文献

1
Brinzolamide encapsulated β-cyclodextrin-chondroitin sulfate nanocomplexes anchored chitosan/polycaprolactone nanofibers as an ocular insert for glaucoma treatment.布林佐胺包封的β-环糊精-硫酸软骨素纳米复合物锚定在壳聚糖/聚己内酯纳米纤维上作为用于青光眼治疗的眼用插入物。
Mater Today Bio. 2025 Aug 11;34:102179. doi: 10.1016/j.mtbio.2025.102179. eCollection 2025 Oct.
2
Roles of biomaterials in modulating the innate immune response in ocular therapy.生物材料在眼部治疗中调节先天性免疫反应的作用。
Front Drug Deliv. 2023 Feb 15;3:1077253. doi: 10.3389/fddev.2023.1077253. eCollection 2023.
3
Recent advancements in polymer science for retinal diseases: New frontiers in drug delivery systems.
用于视网膜疾病的聚合物科学的最新进展:药物递送系统的新前沿。
APL Bioeng. 2025 Jun 27;9(2):020902. doi: 10.1063/5.0264382. eCollection 2025 Jun.
4
Chitosan Nanoparticle-Based Drug Delivery Systems: Advances, Challenges, and Future Perspectives.基于壳聚糖纳米颗粒的药物递送系统:进展、挑战与未来展望
Polymers (Basel). 2025 May 23;17(11):1453. doi: 10.3390/polym17111453.
5
Comparative evaluation of nano ocular delivery systems loaded pH and thermosensitive in situ gels for Acanthamoeba keratitis treatment.负载pH和热敏原位凝胶的纳米眼部给药系统用于棘阿米巴角膜炎治疗的比较评价
Sci Rep. 2025 Jun 3;15(1):19430. doi: 10.1038/s41598-025-03418-5.
6
Chitosan Nanoparticles: Approaches to Preparation, Key Properties, Drug Delivery Systems, and Developments in Therapeutic Efficacy.壳聚糖纳米颗粒:制备方法、关键特性、药物递送系统及治疗效果的进展
AAPS PharmSciTech. 2025 Apr 17;26(5):108. doi: 10.1208/s12249-025-03100-z.
7
Ocular mucoadhesive and biodegradable spanlastics loaded cationic spongy insert for enhancing and sustaining the anti-inflammatory effect of prednisolone Na phosphate; Preparation, I-optimal optimization, and In-vivo evaluation.用于增强和维持磷酸泼尼松龙抗炎作用的眼用粘膜粘附性和可生物降解的Spanlastics负载阳离子海绵插入物;制备、I-最优优化和体内评价
Int J Pharm X. 2024 Oct 16;8:100293. doi: 10.1016/j.ijpx.2024.100293. eCollection 2024 Dec.
8
Biodegradable microspheres come into sight: A promising biomaterial for delivering drug to the posterior segment of the eyeball.可生物降解微球崭露头角:一种有望用于将药物递送至眼球后段的生物材料。
Mater Today Bio. 2024 Jun 13;27:101126. doi: 10.1016/j.mtbio.2024.101126. eCollection 2024 Aug.
9
Chitosan nanoparticles improve the effectivity of miltefosine against Acanthamoeba.壳聚糖纳米粒提高米替福新抗棘阿米巴的效果。
PLoS Negl Trop Dis. 2024 Mar 25;18(3):e0011976. doi: 10.1371/journal.pntd.0011976. eCollection 2024 Mar.
10
Light-responsive polymeric nanoparticles for retinal drug delivery: design cues, challenges and future perspectives.用于视网膜药物递送的光响应性聚合物纳米颗粒:设计要点、挑战与未来展望。
Heliyon. 2024 Feb 18;10(5):e26616. doi: 10.1016/j.heliyon.2024.e26616. eCollection 2024 Mar 15.